Insights from Flagship Biosciences’ team of multidisciplinary experts.
Flagship Biosciences Is Honored with a Best Practices Award
We are honored to announce that Flagship Biosciences has earned a Frost & Sullivan 2023 North American Customer Value Leadership Award in the AI-enabled digital
A Digital Assay to Streamline PD-L1 IHC: Published in Scientific Reports
The journal Scientific Reports recently published a manuscript on the validation of Flagship’s new digital assay, Tissue Insight (TI) 22C3 NSCLC.1 This technology facilitates the
Recognizing women leaders in biotechnology
The COVID-19 pandemic has highlighted the important need for cutting-edge life science research and technology to improve health outcomes. The Healthcare Technology Report recently announced,
Flagship Spotlight: Jordyn Vincelet – Sales Coordinator at Flagship Biosciences
Education and Early Career Jordyn received his Bachelor of Science in Community Health Sciences at the University of Nevada-Reno. Jordyn always wanted to be in
Tissue Based Companion Diagnostics in a Regulated Space
Overview During a recent panel discussion, members of the Flagship Biosciences team and representatives from The Johns Hopkins University, Leap Therapeutics, and Corritori Consulting shared
Flagship Spotlight: Roberto Gianani, MD
Introduction and Background Dr. Roberto Gianani, Chief Medical Officer at Flagship Biosciences, Inc., is a practicing pathologist who is board certified in anatomic pathology, clinical
